Abstract
Preclinical molecular imaging is an invaluable tool to support the discovery and development of clinically relevant imaging and therapeutic reagents. Single-photon emission computed tomography (SPECT) and X-ray computed tomography (CT) are commonly used in clinical nuclear medicine, and these imaging platforms can be utilized in the preclinical setting for discovery, validation, and comparative effectiveness evaluation of novel radiolabeled diagnostic imaging agents. Herein, we discuss these techniques and how we have utilized them to enhance experimental design when evaluating novel radiotracers in vivo. In particular, we focus on the utility of dual-energy SPECT with contrast-enhanced CT and demonstrate how these can be used as exceptional tools for quantitatively and effectively comparing two diagnostic imaging agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Levin CS. Primer on molecular imaging technology. Eur J Nucl Med Mol Imaging. 2005;32(Suppl 2):S325–45. https://doi.org/10.1007/s00259-005-1973-y.
Ziegler S. PET and SPECT. In: Kiessling F, Pichler B, editors. Small animal imaging. Berlin: Springer; 2011. p. 231–6.
Madsen MT. Recent advances in SPECT imaging. J Nucl Med. 2007;48(4):661–73.
Bazanez-Borgert M. Basics of SPECT, PET and PET/CT imaging: JASS; 2006.
Lee CH, Goo JM, Ye HJ, Ye SJ, Park CM, Chun EJ, Im JG. Radiation dose modulation techniques in the multidetector CT era: from basics to practice. Radiographics. 2008;28(5):1451–9. https://doi.org/10.1148/rg.285075075.
Keat N. Report 05016 CT scanner automatic exposure control systems. 2005. http://www.impactscan.org/reports/Report05016. Accessed 2 Feb 2018.
Levine CD, Aizenstein O, Lehavi O, Blachar A. Why we miss the diagnosis of appendicitis on abdominal CT: evaluation of imaging features of appendicitis incorrectly diagnosed on CT. AJR Am J Roentgenol. 2005;184(3):855–9. https://doi.org/10.2214/ajr.184.3.01840855.
Aide N, Kinross K, Beauregard JM, Neels O, Potdevin T, Roselt P, Dorow D, Cullinane C, Hicks RJ. A dual radiologic contrast agent protocol for 18F-FDG and 18F-FLT PET/CT imaging of mice bearing abdominal tumors. Mol Imaging Biol. 2011;13(3):518–25. https://doi.org/10.1007/s11307-010-0378-x.
Thaiss WM, Sauter AW, Bongers M, Horger M, Nikolaou K. Clinical applications for dual energy CT versus dynamic contrast enhanced CT in oncology. Eur J Radiol. 2015;84(12):2368–79. https://doi.org/10.1016/j.ejrad.2015.06.001.
Forghani R, De Man B, Gupta R. Dual-energy computed tomography: physical principles, approaches to scanning, usage, and implementation: Part 2. Neuroimaging Clin N Am. 2017;27(3):385–400. https://doi.org/10.1016/j.nic.2017.03.003.
Silva AC, Morse BG, Hara AK, Paden RG, Hongo N, Pavlicek W. Dual-energy (spectral) CT: applications in abdominal imaging. Radiographics. 2011;31(4):1031–46.; ; discussion 1047–50. https://doi.org/10.1148/rg.314105159.
Histed SN, Lindenberg ML, Mena E, Turkbey B, Choyke PL, Kurdziel KA. Review of functional/anatomical imaging in oncology. Nucl Med Commun. 2012;33(4):349–61. https://doi.org/10.1097/MNM.0b013e32834ec8a5.
Mariani G, Bruselli L, Kuwert T, Kim EE, Flotats A, Israel O, Dondi M, Watanabe N. A review on the clinical uses of SPECT/CT. Eur J Nucl Med Mol Imaging. 2010;37(10):1959–85. https://doi.org/10.1007/s00259-010-1390-8.
Bernsen MR, Vaissier PE, Van Holen R, Booij J, Beekman FJ, de Jong M. The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI. Eur J Nucl Med Mol Imaging. 2014;41(Suppl 1):S36–49.
Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, Scheidhauer K, Wester HJ, Rummeny EJ, Schwaiger M, Drzezga A. Spect/Ct. J Nucl Med. 2008;49(8):1305–19. https://doi.org/10.2967/jnumed.107.050195.
Seo Y, Mari C, Hasegawa BH. Technological development and advances in single-photon emission computed tomography/computed tomography. Semin Nucl Med. 2008;38(3):177–98. https://doi.org/10.1053/j.semnuclmed.2008.01.001.
Ma KH, Huang WS, Chen CH, Lin SZ, Wey SP, Ting G, Wang SD, Liu HW, Liu JC. Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys. Nucl Med Biol. 2002;29(5):561–7.
Martin EB, Williams A, Richey T, Stuckey A, Heidel RE, Kennel SJ, Wall JS. Comparative evaluation of p5+14 with SAP and peptide p5 by dual-energy SPECT imaging of mice with AA amyloidosis. Sci Rep. 2016;6:22695. https://doi.org/10.1038/srep22695.
Meikle SR, Kench P, Kassiou M, Banati RB. Small animal SPECT and its place in the matrix of molecular imaging technologies. Phys Med Biol. 2005;50(22):R45–61. https://doi.org/10.1088/0031-9155/50/22/R01.
Nakazawa A, Ikeda K, Ito Y, Iwase M, Sato K, Ueda R, Dohi Y. Usefulness of dual 67Ga and 99mTc-sestamibi single-photon-emission CT scanning in the diagnosis of cardiac sarcoidosis. Chest. 2004;126(4):1372–6. https://doi.org/10.1378/chest.126.4.1372.
Sanchez-Crespo A, Petersson J, Nyren S, Mure M, Glenny RW, Thorell JO, Jacobsson H, Lindahl SG, Larsson SA. A novel quantitative dual-isotope method for simultaneous ventilation and perfusion lung SPET. Eur J Nucl Med Mol Imaging. 2002;29(7):863–75. https://doi.org/10.1007/s00259-002-0803-8.
Wall JS, Richey T, Williams A, Stuckey A, Osborne D, Martin E, Kennel SJ. Comparative analysis of peptide p5 and serum amyloid P component for imaging AA amyloid in mice using dual-isotope SPECT. Mol Imaging Biol. 2012;14(4):402–7. https://doi.org/10.1007/s11307-011-0524-0.
Weinmann P, Faraggi M, Moretti JL, Hannequin P. Clinical validation of simultaneous dual-isotope myocardial scintigraphy. Eur J Nucl Med Mol Imaging. 2003;30(1):25–31. https://doi.org/10.1007/s00259-002-0995-y.
Lee S, Gregor J, Kennel SJ, Osborne DR, Wall J. GATE validation of standard dual energy corrections in small animal SPECT-CT. PLoS One. 2015;10(4):e0122780. https://doi.org/10.1371/journal.pone.0122780.
Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2015; https://doi.org/10.1016/S0140-6736(15)01274-X.
Hazenberg BP, van Rijswijk MH, Piers DA, Lub-de Hooge MN, Vellenga E, Haagsma EB, Hawkins PN, Jager PL. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am J Med. 2006;119(4):355 e315–24. https://doi.org/10.1016/j.amjmed.2005.08.043.
Dorbala S, Vangala D, Semer J, Strader C, Bruyere JR Jr, Di Carli MF, Moore SC, Falk RH. Imaging cardiac amyloidosis: a pilot study using (18)F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging. 2014;41(9):1652–62. https://doi.org/10.1007/s00259-014-2787-6.
Law WP, Wang WY, Moore PT, Mollee PN, Ng AC. Cardiac amyloid imaging with 18F-Florbetaben PET: a pilot study. J Nucl Med. 2016;57(11):1733–9. https://doi.org/10.2967/jnumed.115.169870.
Osborne DR, Acuff SN, Stuckey A, Wall JS. A routine PET/CT protocol with streamlined calculations for assessing cardiac amyloidosis using (18)F-Florbetapir. Front Cardiovasc Med. 2015;2:23. https://doi.org/10.3389/fcvm.2015.00023.
Rossi P, Tessonnier L, Frances Y, Mundler O, Granel B. 99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis. Clin Nucl Med. 2012;37(8):e209–10. https://doi.org/10.1097/RLU.0b013e318248512c.
Wall JS, Martin EB, Richey T, Stuckey AC, Macy S, Wooliver C, Williams A, Foster JS, McWilliams-Koeppen P, Uberbacher E, Cheng X, Kennel SJ. Preclinical validation of the heparin-reactive peptide p5+14 as a molecular imaging agent for visceral amyloidosis. Molecules. 2015;20(5):7657–82. https://doi.org/10.3390/molecules20057657.
Martin EB, Williams A, Richey T, Wooliver C, Stuckey A, Foster JS, Kennel SJ, Wall JS. Evaluation of the effect of D-amino acid incorporation into amyloid-reactive peptides. J Transl Med. 2017;15(1):247. https://doi.org/10.1186/s12967-017-1351-0.
Martin EB, Kennel SJ, Richey T, Wooliver C, Osborne D, Williams A, Stuckey A, Wall JS. Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: a positive role for peptide dehalogenation. Peptides. 2014;60:63–70. https://doi.org/10.1016/j.peptides.2014.07.024.
Wall JS, Paulus MJ, Gleason S, Gregor J, Solomon A, Kennel SJ. Micro-imaging of amyloid in mice. Methods Enzymol. 2006;412:161–82. https://doi.org/10.1016/S0076-6879(06)12011-X.
Magota K, Kubo N, Kuge Y, Nishijima K, Zhao S, Tamaki N. Performance characterization of the Inveon preclinical small-animal PET/SPECT/CT system for multimodality imaging. Eur J Nucl Med Mol Imaging. 2011;38(4):742–52. https://doi.org/10.1007/s00259-010-1683-y.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Martin, E.B., Stuckey, A., Kennel, S.J., Wall, J.S. (2019). Dual-Energy SPECT Imaging with Contrast-Enhanced CT: A Case Study. In: Kuntner-Hannes, C., Haemisch, Y. (eds) Image Fusion in Preclinical Applications. Springer, Cham. https://doi.org/10.1007/978-3-030-02973-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-02973-9_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-02972-2
Online ISBN: 978-3-030-02973-9
eBook Packages: MedicineMedicine (R0)